An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1
Acinetobacter baumannii is a problematic pathogen due to its common expression of extensive drug resistance (XDR) and ability to survive in the healthcare environment. These characteristics are mediated, in part, by the signal transduction system BfmR/BfmS. We previously demonstrated, in antimicrobi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2020.595798/full |
id |
doaj-9229fb22507341fead1b8da32e26f34f |
---|---|
record_format |
Article |
spelling |
doaj-9229fb22507341fead1b8da32e26f34f2020-11-25T03:39:26ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2020-10-011110.3389/fmicb.2020.595798595798An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1Candace M. Marr0Candace M. Marr1Ulrike MacDonald2Ulrike MacDonald3Grishma Trivedi4Grishma Trivedi5Somnath Chakravorty6Thomas A. Russo7Thomas A. Russo8Thomas A. Russo9Thomas A. Russo10Department of Medicine, University at Buffalo, Buffalo, NY, United StatesErie County Medical Center, Buffalo, NY, United StatesDepartment of Medicine, University at Buffalo, Buffalo, NY, United StatesVeterans Affairs Western New York Healthcare System, Buffalo, NY, United StatesDepartment of Medicine, University at Buffalo, Buffalo, NY, United StatesVeterans Affairs Western New York Healthcare System, Buffalo, NY, United StatesDepartment of Medicine, University at Buffalo, Buffalo, NY, United StatesDepartment of Medicine, University at Buffalo, Buffalo, NY, United StatesVeterans Affairs Western New York Healthcare System, Buffalo, NY, United StatesDepartment of Microbiology and Immunology, University at Buffalo, Buffalo, NY, United StatesWitebsky Center for Microbial Pathogenesis, University at Buffalo, Buffalo, NY, United StatesAcinetobacter baumannii is a problematic pathogen due to its common expression of extensive drug resistance (XDR) and ability to survive in the healthcare environment. These characteristics are mediated, in part, by the signal transduction system BfmR/BfmS. We previously demonstrated, in antimicrobial sensitive clinical isolates, that BfmR conferred increased resistance to meropenem and polymyxin E. In this study, potential mechanisms were informed, in part, by a prior transcriptome analysis of the antimicrobial sensitive isolate AB307-0294, which identified the porins OprB and aquaporin (Omp33-36, MapA) as plausible mediators for resistance to hydrophilic antimicrobials such as meropenem. Studies were then performed in the XDR isolate HUMC1, since delineating resistance mechanisms in this genomic background would be more translationally relevant. In HUMC1 BfmR likewise increased meropenem and polymyxin E resistance and upregulated gene expression of OprB and aquaporin. However, the comparison of HUMC1 with isogenic mutant constructs demonstrated that neither OprB nor aquaporin affected meropenem resistance; polymyxin E susceptibility was also unaffected. Next, we determined whether BfmR-mediated biofilm production affected either meropenem or polymyxin E susceptibilities. Interestingly, biofilm formation increased resistance to polymyxin E, but had little, if any effect on meropenem activity. Additionally, BfmR mediated meropenem resistance, and perhaps polymyxin E resistance, was due to BfmR regulated factors that do not affect biofilm formation. These findings increase our understanding of the mechanisms by which BfmR mediates intrinsic antimicrobial resistance in a clinically relevant XDR isolate and suggest that the efficacy of different classes of antimicrobials may vary under biofilm inducing conditions.https://www.frontiersin.org/articles/10.3389/fmicb.2020.595798/fullAcinetobacter baumanniimeropenempolymyxin Eextensively drug resistantbiofilmBfmR |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Candace M. Marr Candace M. Marr Ulrike MacDonald Ulrike MacDonald Grishma Trivedi Grishma Trivedi Somnath Chakravorty Thomas A. Russo Thomas A. Russo Thomas A. Russo Thomas A. Russo |
spellingShingle |
Candace M. Marr Candace M. Marr Ulrike MacDonald Ulrike MacDonald Grishma Trivedi Grishma Trivedi Somnath Chakravorty Thomas A. Russo Thomas A. Russo Thomas A. Russo Thomas A. Russo An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1 Frontiers in Microbiology Acinetobacter baumannii meropenem polymyxin E extensively drug resistant biofilm BfmR |
author_facet |
Candace M. Marr Candace M. Marr Ulrike MacDonald Ulrike MacDonald Grishma Trivedi Grishma Trivedi Somnath Chakravorty Thomas A. Russo Thomas A. Russo Thomas A. Russo Thomas A. Russo |
author_sort |
Candace M. Marr |
title |
An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1 |
title_short |
An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1 |
title_full |
An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1 |
title_fullStr |
An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1 |
title_full_unstemmed |
An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1 |
title_sort |
evaluation of bfmr-regulated antimicrobial resistance in the extensively drug resistant (xdr) acinetobacter baumannii strain humc1 |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Microbiology |
issn |
1664-302X |
publishDate |
2020-10-01 |
description |
Acinetobacter baumannii is a problematic pathogen due to its common expression of extensive drug resistance (XDR) and ability to survive in the healthcare environment. These characteristics are mediated, in part, by the signal transduction system BfmR/BfmS. We previously demonstrated, in antimicrobial sensitive clinical isolates, that BfmR conferred increased resistance to meropenem and polymyxin E. In this study, potential mechanisms were informed, in part, by a prior transcriptome analysis of the antimicrobial sensitive isolate AB307-0294, which identified the porins OprB and aquaporin (Omp33-36, MapA) as plausible mediators for resistance to hydrophilic antimicrobials such as meropenem. Studies were then performed in the XDR isolate HUMC1, since delineating resistance mechanisms in this genomic background would be more translationally relevant. In HUMC1 BfmR likewise increased meropenem and polymyxin E resistance and upregulated gene expression of OprB and aquaporin. However, the comparison of HUMC1 with isogenic mutant constructs demonstrated that neither OprB nor aquaporin affected meropenem resistance; polymyxin E susceptibility was also unaffected. Next, we determined whether BfmR-mediated biofilm production affected either meropenem or polymyxin E susceptibilities. Interestingly, biofilm formation increased resistance to polymyxin E, but had little, if any effect on meropenem activity. Additionally, BfmR mediated meropenem resistance, and perhaps polymyxin E resistance, was due to BfmR regulated factors that do not affect biofilm formation. These findings increase our understanding of the mechanisms by which BfmR mediates intrinsic antimicrobial resistance in a clinically relevant XDR isolate and suggest that the efficacy of different classes of antimicrobials may vary under biofilm inducing conditions. |
topic |
Acinetobacter baumannii meropenem polymyxin E extensively drug resistant biofilm BfmR |
url |
https://www.frontiersin.org/articles/10.3389/fmicb.2020.595798/full |
work_keys_str_mv |
AT candacemmarr anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT candacemmarr anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT ulrikemacdonald anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT ulrikemacdonald anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT grishmatrivedi anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT grishmatrivedi anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT somnathchakravorty anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT thomasarusso anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT thomasarusso anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT thomasarusso anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT thomasarusso anevaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT candacemmarr evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT candacemmarr evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT ulrikemacdonald evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT ulrikemacdonald evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT grishmatrivedi evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT grishmatrivedi evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT somnathchakravorty evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT thomasarusso evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT thomasarusso evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT thomasarusso evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 AT thomasarusso evaluationofbfmrregulatedantimicrobialresistanceintheextensivelydrugresistantxdracinetobacterbaumanniistrainhumc1 |
_version_ |
1724538873801867264 |